Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.

The Advent and ideation

Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.

Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.

“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.

No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.

FDA's Role in the Push

The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.

Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.

What Could Be The Challenges?

Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.

Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.

Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.

Could Low-Nicotine Cigarettes Be The Solution?

Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.

Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.

One of the beloved football legends, Kevin Keegan, has revealed his ongoing fight with stage four cancer. The news of his health condition has brought on massive support and love from across the football-loving community. The man who inspired generations and contributed both as a player and manager comes forth and reveals that he is getting diagnosed with stage four stomach cancer, and the lethal disease has spread to his other body parts.

The news carried huge value as the former England captain himself talked about his health condition with his usual honesty and humor. The player hailed by his fans as "King Kev" addressed a huge audience in Newcastle. The 75-year-old veteran footballing genius unraveled his journey through the difficult times. His supporters also listened to his self-reflection on the situation completely in silence.

Former Newcastle forward and manager, standing at the Tyne Theatre and Opera House, said, "I was in a car accident and, through that, I had to have an operation. Whilst having the scan for the operation, they found out I had cancer. They said they had an absolute top doctor for fighting what you have got, which is stage four cancer."

"So I went to meet him. He's a Liverpool supporter, so I knew I wouldn't walk alone," he added and continued, "He said, 'Kevin, this new treatment, I've got a tremendous strike rate'. I said, "'What's your strike rate?' He said, '33%'. I thought it would be 80%, 90%. 33%!"

Keegan enjoyed great spells at Scunthorpe United, Liverpool, Hamburg, Southampton, and Newcastle during his illustrious career. Later, he led Newcastle, Fulham, England, and Manchester City.

The player, also popular for his perm hairstyle, was a famous face in British television as a guest on shows and part of an advertisement campaign. He also took part in a public information short-film teaching youngsters how to cross the road. He also brought several pop singles and had a memorable appearance on the television show Superstars.

Also Read: Potential 'Functional Cure' For Hepatitis B: Trial Give Hope To Millions

How To Reduce The Risk Of Cancer?

Consuming a healthy and balanced diet rich in fruits, vegetables, whole grains, and lean proteins can reduce cancer risk.

Regular physical activity keeps the body fit and reduces the risk of breast, colon, and endometrial cancers.

Smoking and alcohol consumption should be avoided.

Skin cancer is one of the most preventable types of cancer. Applying sunscreen with high SPF, finding shade, and avoiding tanning beds would save you from harmful ultraviolet rays.

Also Read: Space Grown Stem Cells: How Are Expedition 74 Astronauts Helping To Fight Cancer?

Long-term stress can weaken the immune system and may contribute to an increased risk of cancer. Incorporating stress-relief techniques such as mindfulness, practising deep-breathing exercises, and engaging in enjoyable hobbies can enhance overall well-being.

Exposure to environmental elements like pesticides, pollutants, and workplace chemicals can increase the risk of cancer. To avoid this risk, wearing protective gear, opting for organic produce, and ensuring adequate ventilation in living or working areas can greatly assist.

By vaccinating against Hepatitis B and HPV, individuals can protect themselves against infections closely linked to liver and cervical cancers; apart from vaccination, adopting proper hygiene practices and steering clear of high-risk activities can help prevent the risk of cancer-causing infections.

Bangladesh’s deadliest measles outbreak is showing no signs of abating. Since March, the highly infectious disease has claimed nearly 600 children, while suspected cases have crossed 72,000.

What is more worrying is that there are no signs of a slowdown despite nationwide vaccination efforts, and experts believe infections could surge further following increased transmission during the Eid Al-Adha homecoming period.

“Over the weekend, Bangladesh documented more than 1,300 suspected measles cases and two deaths, pushing the country’s tally to nearly 71,000 infections and 585 fatalities since the outbreak began in mid-March,” according to the Bangladeshi Directorate General of Health Services (DGHS).

As many as 56,886 suspected measles patients have been hospitalized in Bangladesh since March 15, of whom 52,841 have recovered, according to the DGHS, United News of Bangladesh reported.

“There is no sign of a downtrend in measles infection rate across the country,” Dr. Ariful Bashar from Mohakhali Contagious Disease Hospital told Arab News.

“Measles is a highly contagious disease, even six times more than COVID-19. Unless 95 percent immunity is achieved through vaccination, there will be no downtrend in the infection rate,” he added.

Also read: Measles Again On The Rise Globally: Is India At Risk?

Notably, millions of Bangladeshis travelled to their hometowns last week to celebrate Eid Al-Adha.

Bashar said that “as health protocols were not maintained properly”, the country is likely to “witness a future increase in the infection rate”.

The expert noted that Bangladesh also lacks facilities for efficient contact tracing of measles patients, which could further increase the spread of what he described as “the most contagious disease in the world”.

Hospitals Overwhelmed

Since March, hospitals across the country have been overwhelmed as they struggle to isolate and treat hundreds of children admitted every day.

Dr. Mirza Ziaul Islam, director of the Bangladesh Shishu Hospital and Institute, told Arab News that “during the Eid travel period, it was not possible to keep infected patients isolated”, increasing the risk of further transmission.

Also read: India Concerned Over Measles Outbreak, Action Underway: Dr N K Arora| Exclusive

Most Cases And Deaths Among Young Children

Four out of five measles patients are younger than five years, according to The New York Times. The vast majority of deaths have also occurred in this age group, which is highly vulnerable to the airborne virus.

According to the United Nations International Children's Emergency Fund (UNICEF), Bangladesh had largely contained measles outbreaks since the 1990s through vaccination campaigns. However, immunization efforts were disrupted in 2024 after student-led protests overthrew the government.

The interim administration that governed Bangladesh until elections in late February did not conduct a supplementary mass vaccination campaign as recommended.

Last week, UNICEF said it had repeatedly warned the country’s interim government, led by Muhammad Yunus, through written communications and meetings with Health Ministry officials about vaccine shortages that could trigger a major health crisis, local media reported.

Vaccination Drive Underway

In April, Bangladesh’s new government launched an emergency campaign to vaccinate 20 million children.

Although the campaign has reportedly achieved 110 percent of its target and remains ongoing, experts note that only one of the two doses required for strong and durable immunity has been administered so far.

In addition, it takes four to six weeks for immunity to develop after vaccination.

Outbreak Spreads Nationwide

The outbreak began in January in Rohingya refugee camps near the Myanmar border and quickly spread nationwide. It has now reached 58 of Bangladesh’s 64 districts, causing more than 21,000 hospitalisations.

In an April 23 update, the World Health Organization (WHO) warned of a “considerable risk” of spread to Myanmar, where civil strife has disrupted immunisation efforts, and to India, which remains vulnerable. WHO described the outbreak as “a reversal from Bangladesh’s previous progress towards measles elimination.”

Scientists in Cuba have developed a novel vaccine against lung cancer that has shown the potential to improve survival rates among people living with the disease.

The vaccine, chemically known as racotumomab, has been developed in collaboration with scientists from Argentina. Vaxira has been approved in Cuba and Argentina for advanced non-small cell lung cancer (NSCLC).

How Does Vaxira Work?

It helps the immune system recognize and destroy lung cancer cells.

According to the Cuban Embassy in the US, the vaccine "works by mimicking a molecule found on cancer cells but almost entirely absent in healthy human tissue". It also targets tumors with remarkable precision and has very few side effects.

While advanced NSCLC has limited curative options and poor survival rates, clinical trials of Vaxira showed a significant improvement in survival.

Notably, "one-year survival among patients receiving the vaccine nearly doubled compared with the control group," the post said.

"Real-world data shows median survival of up to 24.5 months in maintenance therapy," it added.

Improved Survival And Minimal Side Effects

Importantly, the vaccine has demonstrated minimal side effects and is considered suitable for long-term use.

The embassy described the vaccine as affordable and accessible compared with many immunotherapies.

In 2025, Vaxira also received Cuba's National Technological Innovation Award.

The commercial rollout of Vaxira is being facilitated by the international public-private consortium ReComBio, linking Havana's Center of Molecular Immunology (CIM) with Argentina's Elea Laboratories.

Also read: Potential 'Functional Cure' For Hepatitis B: Trial Give Hope To Millions

What Is Lung Cancer?

Lung Cancer is one of the most common and serious types of cancer. It is also the leading cause of cancer-related deaths worldwide, with approximately 2.5 million new cases and 1.8 million deaths reported in 2022.

According to the American Cancer Society, lung cancer mainly occurs in older people. Most people diagnosed with lung cancer are 65 or older; a very small number of people diagnosed are younger than 45.

The average age of people when diagnosed is about 70.

It is also the leading cause of cancer death in the US, accounting for about 1 in 5 of all cancer deaths.

The two main types of lung cancers are:

Non-small-cell lung cancer (NSCLC): This is the most common form, making up about 80–85% of all cases. NSCLC includes three subtypes:

• Squamous cell carcinoma
• Adenocarcinoma
• Large-cell carcinoma

Small-cell lung cancer (SCLC): Less common than NSCLC, this type tends to grow and spread more quickly.

Early Signs and Symptoms to Look Out For

Lung cancer symptoms can mimic less serious conditions, which is why they’re often dismissed or misdiagnosed. If you experience the following symptoms persistently, don’t ignore them—regardless of your age or smoking history:

• Chest pain or discomfort
• Unexplained shortness of breath
• Persistent cough or wheezing
• Shoulder, back, or rib pain
• Fatigue or sudden weight loss
• Blood in sputum (though not always present).